Baidu
map
HEPATOBIL SURG NUTR 润色咨询

Hepatobiliary Surgery and Nutrition

出版年份：暂无数据 年文章数：232 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2024-08-22 ms5000000711521518 来自新疆

    first decision多久啊

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2022-05-11 ms8000001954244823

    投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2023-12-19 ms2000000991085016 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2023-05-24 sur_wu 来自上海

    有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2023-05-24 sur_wu 来自上海

    有人知道为什么文章见刊后在pubmed上检索不到是怎么回事

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2021-01-19 ms7000000793778495

    请问这个杂志的in review是在编辑手里还是送外审？

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2021-11-18 dr大王

    中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2021-11-08 ms1000000378835503

    之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2019-12-23 你们慢慢聊

    贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter....

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068146, encodeId=1ce7106814637, content=之前同学投稿的journal of hepatology的文章二审被拒，后来转投了HBSN，顺利接收了，如果文章质量可以，还是建议，毕竟现在强调把论文发在祖国大地上嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=974e5698679, createdName=ms1000000378835503, createdTime=Mon Nov 08 16:01:41 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582058, encodeId=da1f5820582c, content=贡献下评论，被拒了，编辑说最近的拒稿率76%，叫我转投letter...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0d2371296, createdName=你们慢慢聊, createdTime=Mon Dec 23 20:32:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917960, encodeId=ee0991e960b0, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=蛋疼哥, createdTime=Tue Jan 19 09:16:34 CST 2021, time=2021-01-19, status=1, ipAttribution=)]
    2021-01-19 蛋疼哥

    请问这个杂志的in review是在编辑手里还是送外审？

    1

    展开1条回复
共31条页码: 1/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map